title: Revisiting the putative TCR Cα dimerization model through structural analysis.
abstract: Despite major advances in T cell receptor (TCR) biology and structure, how peptide-MHC complex (pMHC) ligands trigger αβ TCR activation remains unresolved. Two views exist. One model postulates that monomeric TCR-pMHC ligation events are sufficient while a second proposes that TCR-TCR dimerization in cis via Cα domain interaction plus pMHC binding is critical. We scrutinized 22 known TCR/pMHC complex crystal structures, and did not find any predicted molecular Cα-Cα contacts in these crystals that would allow for physiological TCR dimerization. Moreover, the presence of conserved glycan adducts on the outer face of the Cα domain preclude the hypothesized TCR dimerization through the Cα domain. Observed functional consequences of Cα mutations are likely indirect, with TCR microclusters at the immunological synapse driven by TCR transmembrane/cytoplasmic interactions via signaling molecules, scaffold proteins, and/or cytoskeletal elements.
authors: Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA ; Department of Pediatrics, Harvard Medical School Boston, MA, USA ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Boston, MA, USA.
authors: Jia-Huai
authors: JH
authors: Wang
authors: Ellis L
authors: EL
authors: Reinherz
keywords: TCR; receptor dimerization; signal transduction; structural immunology
references: Immunol Rev. 2012 Nov;250(1):102-19
references: 23046125
references: Trends Immunol. 2010 Jan;31(1):1-6
references: 19836999
references: Immunity. 1999 Feb;10(2):227-37
references: 10072075
references: J Immunol. 2010 Jun 1;184(11):5959-63
references: 20435924
references: Nat Rev Immunol. 2008 Sep;8(9):699-712
references: 18728635
references: Biochem J. 1997 Apr 15;323 ( Pt 2):415-9
references: 9163332
references: Biophys J. 2012 Jan 18;102(2):L5-7
references: 22339876
references: Nature. 1997 Jun 5;387(6633):617-20
references: 9177351
references: Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5094-9
references: 20202921
references: J Biol Chem. 2012 Apr 13;287(16):13324-35
references: 22262845
references: Cell. 2002 Sep 20;110(6):669-72
references: 12297041
references: Front Immunol. 2012 Apr 18;3:76
references: 22566957
references: J Exp Med. 1983 Sep 1;158(3):988-93
references: 6604129
references: Annu Rev Immunol. 2006;24:419-66
references: 16551255
references: Nat Struct Biol. 1998 Nov;5(11):938-40
references: 9808034
references: EMBO J. 1998 Jan 2;17(1):10-26
references: 9427737
references: Immunity. 2008 Oct 17;29(4):589-601
references: 18848472
references: PLoS One. 2011 May 10;6(5):e19680
references: 21572959
references: Annu Rev Immunol. 2009;27:591-619
references: 19132916
references: J Immunol. 2014 May 1;192(9):4015-6
references: 24748635
references: Nature. 2011 Jul 19;477(7366):549-55
references: 21772288
references: Science. 1992 Jan 3;255(5040):79-82
references: 1532456
references: Nat Rev Immunol. 2011 Jan;11(1):47-55
references: 21127503
references: Immunity. 1998 Oct;9(4):459-66
references: 9806632
references: Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5405-10
references: 22431638
references: J Biol Chem. 2009 Nov 6;284(45):31028-37
references: 19755427
references: Front Immunol. 2012 Jun 25;3:159
references: 22737151
references: Nature. 2005 Mar 10;434(7030):238-43
references: 15724150
references: Science. 1991 Nov 8;254(5033):821-5
references: 1948064
references: Immunity. 2001 Jun;14(6):681-92
references: 11420039
references: Science. 2001 Mar 23;291(5512):2370-6
references: 11269318
references: Proc Natl Acad Sci U S A. 1984 Mar;81(5):1509-13
references: 6231642
references: Science. 1992 Jan 17;255(5042):306-12
references: 1549776
references: Immunol Rev. 2009 Mar;228(1):41-57
references: 19290920